Filing Flows › Cardlytics (CDLX) › Q3 2026
Cardlytics (CDLX) Q3 2026 earnings results (third quarter 2026)
10-Q filed Nov 5, 2026
Cardlytics (CDLX) reported revenue of $32.9M for the third quarter 2026 (Q3 2026), -30% from a year earlier and -11% from the quarter before. Operating margin was -16.5%, net loss $8.9M (27.2% of revenue).
Cardlytics, Q3 2026: revenue $32.9M (-30% year over year), operating margin -16.5%, net loss $8.9M, operating cash flow −$5.9M. The chart follows the revenue to costs, profit and cash.
| Q3 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $32.9M | -11% | -30% |
| Operating profit | −$5.4M | — | — |
| Net earnings | −$8.9M | — | — |
| Operating cash flow | −$5.9M | — | -435% |
What changed
Revenue was $32.9M in Q3 2026, down 30% year over year and down 11% from the previous quarter. Engagement based pricing was the largest line at 66% of revenue. Served based pricing lost $8.1M year over year (down 44%), 57% of the total change.
Operating costs exceeded revenue by $5.4M, an operating margin of -16.5%. Total costs fell 66% while revenue fell 30%. The quarter ended with a net loss of $8.9M, narrower than the previous quarter's $14.9M loss.
Operating cash flow was −$5.9M. Non-cash charges added back $4.2M of depreciation and amortization and $1.6M of share-based compensation. Working capital and other items used $2.8M. Capital expenditures of $20K exceeded it, leaving free cash flow of −$5.9M.
Questions
What was Cardlytics' revenue in the third quarter 2026?
Cardlytics (CDLX) reported revenue of $32.9M for the third quarter 2026 (Q3 2026), -30% from a year earlier and -11% from the quarter before.
Was Cardlytics profitable in the third quarter 2026?
Operating loss was $5.4M (-16.5% of revenue) and net loss $8.9M.
Source: Cardlytics 10-Q on SEC EDGAR.